ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Chemo Combinations Tested In Phase III For Lung Cancer

August 31, 2001

Health Organizations Endorse “Patients’ Rights” Document

November 17, 1995

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002

The Avastin Story In A Nutshell: A Timeline

May 27, 2011